Preview

Siberian journal of oncology

Advanced search

EPIDEMIOLOGY OF LIVER CANCER. MORBIDITY, MORTALITY, DYNAMICS OF HISTOLOGICAL STRUCTURE

Abstract

Primary liver cancer is the ICD-10 category C22 (malignant tumors of the liver and intrahepatic bile ducts). This is one of the most severe forms of cancer. According to database (DB) of the Population-based Cancer Registry of St. Petersburg for the past 15 years the median of cumulative observed survival of liver cancer patients of all histological forms (excluding postmortem diagnosed patients) both for men and women was no more than 3.3 months from the moment of diagnosis. On the majority of administrative territories of Russia mortality from liver cancer exceeds the level of morbidity that indicates a significant underestimation of primary patients. Even mortality («rude» rate) for Russia in the whole for men in 2012 exceeded the level of morbidity. St. Petersburg (Leningrad) is the single territory of Russia where the dynamics of the population liver cancer incidence can be analyzed since 1980. Dynamics of histological structure of liver cancer, recorded in St. Petersburg, shows a sharp decline in the proportion of tumors of the liver without a specific histological type and the significant increase in hepatocellular carcinoma and cholangiocarcinoma. Purpose of the study. To study the prevalence of liver cancer in the world and Russia, to produce in-depth development of material based on DB of the Population-based Cancer Registry of St. Petersburg. Material and methods. For the study there were taken by international data of the program «Cancer in 5 continents», statistical materials on Russia, 3893 cases from DB of the Population-based Cancer Registry of St. Petersburg, estimated analytical indices, index accuracy. Results of the study. Liver cancer is the most severe form of cancer. It is practically not detected in stage I and II of disease, index of accuracy in the most administrative territories exceeds 1.0. Conclusion. Thus liver cancer is not only one of tumors with the highest lethality and the lowest median of survival but also has a significant underestimation of the primary cases. Since the introduction in public reporting data on deaths from liver cancer in 1999 the standardized mortality rate in St. Petersburg decreased by 17.2 % in men and 16.0 % women.

About the Authors

V. M. Merabishvili
N.N. Petrov Research Institute of Oncology, St. Petersburg
Russian Federation

Merabishvili Vakhtang Mikhailovich - MD, DSc, Professor, Chairman of the Scientific - Methodical Council for the Development of Information Systems of Oncology Service of the North-West region of Russia, Head of the Cancer Control Department.
Phone: +7 812 439-95-47, +7 964 337-83-10, E-mail: MVM@niioncologii.ru, bogdanova.k@mail.ru



E. N. Merabishvili
Northwestern State Medical University named after I.I.Mechnikov, St. Petersburg
Russian Federation

Chepic Oleg Fyedorovich - MD., DSc, Professor, Principal Investigator of the Tumor Morphology. Department .
Phone: +7 812 439-95-33, +7 439-95-47. Email: MVM@niioncologii.ru



O. F. Chepik
N.N. Petrov Research Institute of Oncology, St. Petersburg
Russian Federation

Merabishvili Elvira Nazarovna - MD., PhD., Senior Lecturer at the Department of Histology, Cytology and Embryology.
Phone: +7 (812) 545-14-14. E-mail: MVM@niioncologii.ru



References

1. Афанасьев С.Г., Тузиков С.А. Нерезектабельные опухоли печени (обзор литературы) // Сибирский онкологический журнал. 2006. № 1. С. 49–54.

2. Верин В.К., Титова Г.Н., Мерабишвили Э.Н., Иванов В.В., Волкова Р.И., Вереникина Б.И., Чижикова Л.С. Экспериментальный канцерогенез печени, вызванный диметиламиноазотолуолом // Вопро- сы онкологии. 2013. Т. 59. Приложение к № 3 «Онкология XXI века: от научных исследований в клиническую практику. Материалы VIII Всероссийского съезда онкологов». Т. I. С. 41–42.

3. Верин В.К., Титова Г.Н., Мерабишвили Э.Н., Филимонова Г.Ф., Иванов В.В., Вереникина Б.И., Волкова Р.И. Экспериментальный канцерогенез печени, вызванный ортоаминоазотолуолом // Вопр. онкол. 2013. Т. 59. Приложение к № 3 «Онкология XXI века: от научных исследований в клиническую практику. Материалы VIII Всероссийского съезда онкологов». Т. I. С. 40–41.

4. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского,В. Петровой. М., 2014. 250 с.

5. Кощуг Г.Д. Первичный рак печени. Кишинев, 1976. 172 с.

6. Мерабишвили В.М. Динамика показателей деятельности онкологической службы Санкт-Петербурга по районам города в 2010–2012 гг. Экспресс-информация Популяционного ракового ре- гистра. СПб., 2013. 48 с.

7. Мерабишвили В.М. Онкологическая служба Санкт-Петербурга (оперативная отчетность за 2011–2012 годы, углубленная разработка базы данных регистра по международным стандартам). ПРР (IACR №221) / Под ред. В.М. Колабутина, А.М. Беляева. СПб.: Коста, 2013. Т. 18. 364 с.

8. Мерабишвили В.М. Онкологическая статистика (традиционные методы, новые информационные технологии): Руководство для врачей. СПб., 2011. Ч. I. 221 с.

9. Мерабишвили В.М. Онкологическая статистика (традиционные методы, новые информационные технологии): Руководство для врачей. СПб., 2011. Ч. II. 248 с.

10. Опухоли пищеварительного тракта / Под ред. С.С. Чистякова. М., 2011. 200 с.

11. Состояние онкологической помощи населению России в 2012 году / Под ред. А.Д. Каприна, В.В. Старинского,В. Петровой. М., 2012. 231 с.

12. Шайн А.А. Первичный рак печени в Тюменской области: Автореф. дис. … д-ра. мед. наук. М., 1973.

13. Шерлок Ш., Дули Дж. Заболевание печени и желчных путей. М., 1999. 864 с.

14. Bornman P.C., Harries-Jones E.P. Tobias R., Van Stiegmann G., Terblanche J. Prospective controlled trial of transhepatic biliary endopros- thesis versus bypass surgery for incurable carcinoma of head of pancreas // Lancet. 1986. Vol. 1 (8472). P. 69–71.

15. Cancer incidence in five continents // IARC. Sci. Publ. № 160. Vol. IX. Lyon, 2008. 837 p.

16. Cancer Registration Principles and Methods / Ed. O.M. Jensen, D.M. Parkin, R. Maclennan, C.S. Muir and R.G. Skeet // IARC. Scientific. Publ. № 95. Lyon, 1991. 296 p.

17. Mason W.S., Xu C., Aldrich C.E., Saputelli J., Frank K., Wilk M. Hepatitis virus and liver cancer // Scientific Reports. 2004: Basic Science. Medical Science. Fox Chaild. Cancer cent. Philadelphia, 2004. P. 115–118

18. Sarbah S.A., Gramlich T., Younoszai A., Osmack P., Goormastic M., Grosso L., Cooper J.N., Di Bisceglie A., Seneca R., Younossi Z.M. Risk factors for hepatocellular carcinoma in patients with cirrhosis // Dig. Dis. Sci. 2004. Vol. 49 (5). P. 850–853.

19. Statistical Methods in cancer research. Vol. 1. – The analysis of case-control studies / Ed. N.E. Breslow, N.E. Day // IARC Scientific publ. № 32. Lyon. 1980. 343 p.


Review

For citations:


Merabishvili V.M., Merabishvili E.N., Chepik O.F. EPIDEMIOLOGY OF LIVER CANCER. MORBIDITY, MORTALITY, DYNAMICS OF HISTOLOGICAL STRUCTURE. Siberian journal of oncology. 2015;1(2):5-14. (In Russ.)

Views: 2741


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)